Examine Database: Hand-Foot Syndrome
Research FeedRead all studies
Nanosilymarin might reduce hand-foot syndrome risk during chemotherapy for metastatic colorectal cancer
In this pilot randomized controlled trial in 60 adults who were undergoing chemotherapy for metastatic colorectal cancer, supplementation with nanosilymarin reduced the incidence of hand-foot syndrome ( a common chemotherapy side-effect).
Examine Database References
- Hand-Foot Syndrome Symptoms - Corrie PG, Bulusu R, Wilson CB, Armstrong G, Bond S, Hardy R, Lao-Sirieix S, Parashar D, Ahmad A, Daniel F, Hill M, Wilson G, Blesing C, Moody AM, McAdam K, Osborne MA randomised study evaluating the use of pyridoxine to avoid capecitabine dose modificationsBr J Cancer.(2012 Aug 7)
- Hand-Foot Syndrome Symptoms - Jo SJ, Shin H, Jo S, Kwon O, Myung SKProphylactic and therapeutic efficacy of pyridoxine supplements in the management of hand-foot syndrome during chemotherapy: a meta-analysis.Clin Exp Dermatol.(2015 Apr)